CAPR Class Action Lawsuit FILED: Capricor Therapeutics Sued for Securities Fraud after Stock Drops 64% Leading to Securities Fraud Case – Investors Urged to Contact BFA Law businesswire.com August 3, 2026 at 3:46 PM ET CAPR The article reports a class action lawsuit filed against Capricor Therapeutics for securities fraud following a significant stock drop. This indicates strong negative sentiment due to alleged fraudulent activities.